Aman Chauhan, MD, MBBS

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Address654 Minnesota Street
San Francisco CA 94107
PronounsHe/Him/His
vCardDownload vCard

    Collapse Research 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Multi-center Phase 1 study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388). Clin Cancer Res. 2026 Jul 28. Chauhan A, Weiss HL, Kunos C, Jayswal R, Konda B, Soares HP, Li D, Halfdanarson TR, Mulcahy MF, Jacene HA, Khurana A, Modak R, Yan D, Beumer JH, Christner SM, Wu PI, Das B, Rubinstein LV, Gore SD, Ivy SP, Kohn EC, Carson WE, Anthony LB, Arnold SM. PMID: 42518206.
      View in: PubMed   Mentions:    Fields:    
    2. Targeted Radionuclide Therapy: Current Landscape and Combination Approaches to Improve Oncology Outcomes. Clin Cancer Res. 2026 Jul 13. Nonnekens J, Byers LA, Chauhan A, George DJ, Hicks RJ, Weber WA. PMID: 42439911.
      View in: PubMed   Mentions:    Fields:    
    3. The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate Cancer, and Beyond. J Nucl Med. 2026 Jul 01; 67(7):1037-1040. Chauhan A, Hendifar AE, El-Haddad G, Soares HP, Herrmann K. PMID: 42061947.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Tarlatamab in Previously Treated Small Cell Lung Cancer: A Real-World Experience in a Predominantly Hispanic Population with CNS Metastases. Cancers (Basel). 2026 Jun 01; 18(11). Sucre S, Jani C, Morgenstern-Kaplan D, Nelsy Z, Modak R, Edwards K, Rose B, Malik S, Rowley K, Rauf A, Lopes G, Rodriguez E, Chauhan A. PMID: 42279394; PMCID: PMC13255975.
      View in: PubMed   Mentions:
    5. Enhancing triapine treatment: strategies for dose optimization and methemoglobin level mitigation. Cancer Chemother Pharmacol. 2026 May 20; 96(1). Lee H, Dunn A, Taylor SE, Chauhan A, Ivy SP, Gobburu J, Beumer JH. PMID: 42159774; PMCID: PMC13190473.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    6. Phase 2 study of cabozantinib (XL184) with nivolumab and ipilimumab for the treatment of poorly differentiated neuroendocrine carcinomas (ETCTN10315). Oncologist. 2026 May 08; 31(6). Mandl A, Chen R, Das S, Strosberg JR, Kasi A, Konda B, Li D, Burns TF, Chauhan A, Ciombor KK, Dayyani F, Dorff T, Ohr JP, Patel BB, Sukrithan V, Soares HP, Chen K, Liu SV, Tesfaye AA, Carducci MA, Beumer JH. PMID: 41968073; PMCID: PMC13181262.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    7. A case report of acute carcinoid heart failure during lutetium-177 dotatate-triapine treatment for well-differentiated neuroendocrine tumors. Front Oncol. 2026; 16:1801126. Chauhan A, Kohn EC, Ivy SP, Kolesar JM, Modak R, Arnold S, Anthony L, Carson WE, Shelman NR, Kunos CA. PMID: 42180080; PMCID: PMC13194028.
      View in: PubMed   Mentions:
    8. The genomic, transcriptomic, and immunologic landscape of TEM8 (ANTXR1) in neuroendocrine neoplasms (NENs) including small-cell lung cancer (SCLC). Cancer Treat Res Commun. 2026; 47:101190. Kareff SA, Krause H, Elliott A, Samec T, Lopes G, Hosein PJ, Jani CT, Lou E, Soares H, Magistri M, Sumarriva D, Oberley M, Chauhan A. PMID: 42061011.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    9. PRRT for well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Endocr Relat Cancer. 2026 Mar 01; 33(3). Corbett V, Gupta G, Chauhan A. PMID: 41769977; PMCID: PMC13126668.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Treating Pediatric Oncology Patients: The Emerging Role of Radioligand Therapy. Cancers (Basel). 2025 Nov 28; 17(23). Laetsch TW, States LJ, Lazow MA, Chauhan A. PMID: 41375023; PMCID: PMC12691195.
      View in: PubMed   Mentions:
    11. Dethroning of Neuroendocrine Tumor as an Orphan Disease: US Incidence, Prevalence, and Survival in the 21st Century. Cancers (Basel). 2025 Oct 15; 17(20). Yu Q, Cao F, Hosein P, Huang B, Pinheiro PS, Wang Y, Del Rivero J, Lopes G, Chauhan A. PMID: 41154379; PMCID: PMC12563563.
      View in: PubMed   Mentions: 1  
    12. Sequencing Choices and Real-World Clinical Management in Advanced Grade 2/3 GEP-NET Treatment: The Emerging Role of PRRT. Cancers (Basel). 2025 Sep 15; 17(18). Chauhan A, Halfdanarson TR, Vijayvergia N. PMID: 41008852; PMCID: PMC12468650.
      View in: PubMed   Mentions:
    13. Evolving strategies in the management of non-small cell lung cancer brain metastases: insights from the C-Brain trial. Chin Clin Oncol. 2025 Aug; 14(4):49. Jani CT, Lopes G, Hao Z, Chauhan A. PMID: 40897304.
      View in: PubMed   Mentions:    Fields:    
    14. Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline. JCO Oncol Pract. 2026 Jan; 22(1):19-35. Perez K, Del Rivero J, Kennedy EB, Basu S, Chauhan A, Connolly HM, Dasari AN, Gangi A, Clarke CN, Hallet J, Howe JR, Grady E, Ivanidze J, Mittra ES, White SB, Raj NP, Vijayvergia N, Lewis MA, Chan JA, Kunz PL, Mailman J, Arshad J, Soares HP, Singh S, Chandrasekharan C, Soulen MC, Janson ET, Halfdanarson TR, Strosberg JR, Bergsland EK. PMID: 40344544.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    15. Prospects for radioimmunotherapy panaceas in gynecologic oncology. Cancer. 2025 Apr 15; 131(8):e35841. Kunos CA, Chauhan A. PMID: 40193293.
      View in: PubMed   Mentions:    Fields:    
    16. Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892). Cancer Chemother Pharmacol. 2024 Dec 14; 95(1):4. Taylor SE, Behr S, Cooper KL, Mahdi H, Fabian D, Gallion H, Ueland F, Vargo J, Orr B, Girda E, Courtney-Brooks M, Olawaiye AB, Randall LM, Richardson DL, Sullivan SA, Huang M, Christner SM, Beriwal S, Lin Y, Chauhan A, Chu E, Kohn EC, Kunos C, Ivy SP, Beumer JH. PMID: 39673591; PMCID: PMC12183685.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    17. Nemvaleukin alfa, a modified interleukin-2 cytokine, as monotherapy and with pembrolizumab in patients with advanced solid tumors (ARTISTRY-1). J Immunother Cancer. 2024 11 20; 12(11). Vaishampayan UN, Muzaffar J, Winer I, Rosen SD, Hoimes CJ, Chauhan A, Spreafico A, Lewis KD, Bruno DS, Dumas O, McDermott DF, Strauss JF, Chu QS, Gilbert L, Chaudhry A, Calvo E, Dalal R, Boni V, Ernstoff MS, Velcheti V. PMID: 39567211; PMCID: PMC11580269.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    18. Triplet regimen with camrelizumab plus apatinib in combination with hepatic artery infusion chemotherapy (HAIC): a new treatment paradigm for select patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma? Chin Clin Oncol. 2024 Oct; 13(5):80. Gupta G, Patel R, Akce M, Chauhan A. PMID: 39496550.
      View in: PubMed   Mentions:    Fields:    
    19. A neuroendocrine biomarker revolution from monoanalyte to multianalyte biomarkers in non-functioning gastro-entero-pancreatic neuroendocrine neoplasms. Crit Rev Oncol Hematol. 2024 Nov; 203:104460. Hoff CO, Manzi J, Ferreira R, Chauhan A, Housein P, Merchant N, Livingstone A, Vianna R, Abreu P. PMID: 39153703.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. AJCC Cancer Staging System Version 9: Practice-Informing Updates for Gastroenteropancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2024 Aug; 31(8):4834-4836. Chan K, Chauhan A, Shi C. PMID: 38869764.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor. Cancer Lett. 2024 Aug 01; 596:216993. Chow Z, Johnson J, Chauhan A, Jeong JC, Castle JT, Izumi T, Weiss H, Townsend CM, Schrader J, Anthony L, Yang ES, Evers BM, Rychahou P. PMID: 38801884; PMCID: PMC11299177.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    22. Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin. 2024 Jul-Aug; 74(4):359-367. Chauhan A, Chan K, Halfdanarson TR, Bellizzi AM, Rindi G, O'Toole D, Ge PS, Jain D, Dasari A, Anaya DA, Bergsland E, Mittra E, Wei AC, Hope TA, Kendi AT, Thomas SM, Flem S, Brierley J, Asare EA, Washington K, Shi C. PMID: 38685134; PMCID: PMC11938941.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    23. Leveraging Programmatic Collaboration for a Radiopharmaceutical Clinic. Cancers (Basel). 2024 Apr 02; 16(7). Kunos CA, Martin ME, Georgiou MF, Kuker RA, Chauhan A. PMID: 38611074; PMCID: PMC11011188.
      View in: PubMed   Mentions: 1  
    24. Development and validation of a chromatin regulator signature for predicting prognosis hepatocellular carcinoma patient. J Gastrointest Oncol. 2024 Feb 29; 15(1):397-414. Mao J, Song F, Zhang Y, Li Y, Inchingolo R, Chauhan A, Midorikawa Y, Chen Z, Tang W. PMID: 38482221; PMCID: PMC10932653.
      View in: PubMed   Mentions: 3  
    25. Role of CDK4/6 inhibitors in targeting Rb proficient small cell lung cancer. Transl Lung Cancer Res. 2024 Jan 31; 13(1):190-194. Corbett V, Sen T, Chauhan A. PMID: 38404986; PMCID: PMC10891408.
      View in: PubMed   Mentions:
    26. Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial. JAMA Oncol. 2023 12 01; 9(12):1669-1677. Takahashi N, Hao Z, Villaruz LC, Zhang J, Ruiz J, Petty WJ, Mamdani H, Riess JW, Nieva J, Pachecho JM, Fuld AD, Shum E, Chauhan A, Nichols S, Shimellis H, McGlone J, Sciuto L, Pinkiert D, Graham C, Shelat M, Kattappuram R, Abel M, Schroeder B, Upadhyay D, Krishnamurthy M, Sharma AK, Kumar R, Malin J, Schultz CW, Goyal S, Redon CE, Pommier Y, Aladjem MI, Gore SD, Steinberg SM, Vilimas R, Desai P, Thomas A. PMID: 37824137; PMCID: PMC10570917.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    27. TEM8 in Oncogenesis: Protein Biology, Pre-Clinical Agents, and Clinical Rationale. Cells. 2023 11 14; 12(22). Kareff SA, Corbett V, Hallenbeck P, Chauhan A. PMID: 37998358; PMCID: PMC10670355.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline. J Clin Oncol. 2023 11 10; 41(32):5049-5067. Del Rivero J, Perez K, Kennedy EB, Mittra ES, Vijayvergia N, Arshad J, Basu S, Chauhan A, Dasari AN, Bellizzi AM, Gangi A, Grady E, Howe JR, Ivanidze J, Lewis M, Mailman J, Raj N, Soares HP, Soulen MC, White SB, Chan JA, Kunz PL, Singh S, Halfdanarson TR, Strosberg JR, Bergsland EK. PMID: 37774329.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    29. Review of practice informing data and current state of NCCN consensus guidelines in hepatobiliary cancers. Hepatobiliary Surg Nutr. 2023 Oct 01; 12(5):798-803. Corbett V, Li D, Chauhan A. PMID: 37886197; PMCID: PMC10598301.
      View in: PubMed   Mentions: 2  
    30. Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting. J Natl Cancer Inst. 2023 09 07; 115(9):1001-1010. Singh S, Hope TA, Bergsland EB, Bodei L, Bushnell DL, Chan JA, Chasen BR, Chauhan A, Das S, Dasari A, Del Rivero J, El-Haddad G, Goodman KA, Halperin DM, Lewis MA, Lindwasser OW, Myrehaug S, Raj NP, Reidy-Lagunes DL, Soares HP, Strosberg JR, Kohn EC, Kunz PL, NET CTPM participants . PMID: 37255328; PMCID: PMC10483264.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    31. Prescribing Characteristics of Octreotide Immediate-Release and Long-Acting Release in Patients with Neuroendocrine Tumors. Oncologist. 2023 06 02; 28(6):479-485. Cheng Y, Anthony L, Delcher C, Moga DC, Chauhan A, Huang B, Adams V. PMID: 36994847; PMCID: PMC10243760.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Pulmonary large cell neuroendocrine carcinoma (LCNEC): a population-based study addressing recent molecular-genetic advances and emerging therapeutic approaches. Clin Exp Med. 2023 Nov; 23(7):3947-3955. Khan J, Yasinzai AQK, Matosz S, Khan M, Heneidi S, Mesa H, Chauhan A, Del Rivero J, Karim NA, Ullah A. PMID: 37060529.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    33. Treatment Sequencing Strategies in Advanced Neuroendocrine Tumors: A Review. Cancers (Basel). 2022 Oct 26; 14(21). Chauhan A, Del Rivero J, Ramirez RA, Soares HP, Li D. PMID: 36358667; PMCID: PMC9656186.
      View in: PubMed   Mentions: 12  
    34. Real-World Clinical and Patient-Reported Outcomes from the Longitudinal Telotristat Ethyl Treatment Registry of Patients with Neuroendocrine Tumors. Cancer Manag Res. 2022; 14:3009-3020. Li D, Darden C, Osman N, Sayeed S, Jackson L, Garbinsky D, Chauhan A. PMID: 36262750; PMCID: PMC9575469.
      View in: PubMed   Mentions:
    35. Pediatric Neuroendocrine Neoplasms: Rare Malignancies with Incredible Variability. Cancers (Basel). 2022 Oct 15; 14(20). Castle JT, Levy BE, Chauhan A. PMID: 36291833; PMCID: PMC9599522.
      View in: PubMed   Mentions: 4  
    36. Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics. Front Mol Biosci. 2022; 9:930207. Corbett V, Hallenbeck P, Rychahou P, Chauhan A. PMID: 36090051; PMCID: PMC9458967.
      View in: PubMed   Mentions: 10  
    37. Comprehensive Assessment of Somatostatin Receptors in Various Neoplasms: A Systematic Review. Pharmaceutics. 2022 Jul 01; 14(7). Priyadarshini S, Allison DB, Chauhan A. PMID: 35890290; PMCID: PMC9325105.
      View in: PubMed   Mentions: 10  
    38. An Update on the Management of Mixed Neuroendocrine-Non-neuroendocrine Neoplasms (MiNEN). Curr Treat Options Oncol. 2022 05; 23(5):721-735. Jacob A, Raj R, Allison DB, Soares HP, Chauhan A. PMID: 35347561.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    39. hPG80 (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors. Cancers (Basel). 2022 Feb 09; 14(4). Chauhan A, Prieur A, Kolesar J, Arnold S, Payen L, Mahi Y, Vire B, Sands M, Evers BM, Joubert D, Anthony L. PMID: 35205614; PMCID: PMC8870162.
      View in: PubMed   Mentions: 3  
    40. External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide Therapy. JAMA Netw Open. 2022 01 04; 5(1):e2144170. Das S, Chauhan A, Du L, Thomas KE, Jacob A, Schad A, Jain S, Jessop A, Shah C, Eisner D, Cardin DB, Ciombor KK, Goff LW, Bradshaw M, Delbeke D, Sandler M, Ramirez RA, Berlin J. PMID: 35044469; PMCID: PMC8771294.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    41. Management of Large Cell Neuroendocrine Carcinoma. Front Oncol. 2021; 11:653162. Corbett V, Arnold S, Anthony L, Chauhan A. PMID: 34513663; PMCID: PMC8432609.
      View in: PubMed   Mentions: 22  
    42. Adjuvant therapy for lung neuroendocrine neoplasms. World J Clin Oncol. 2021 Aug 24; 12(8):664-674. Ramirez RA, Thomas K, Jacob A, Lin K, Bren-Mattison Y, Chauhan A. PMID: 34513600; PMCID: PMC8394158.
      View in: PubMed   Mentions: 6  
    43. Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma. Front Oncol. 2021; 11:653153. Saghaeiannejad Esfahani H, Vela CM, Chauhan A. PMID: 34141612; PMCID: PMC8203494.
      View in: PubMed   Mentions: 14  
    44. Can an amino acid mixture alleviate gastrointestinal symptoms in neuroendocrine tumor patients? BMC Cancer. 2021 May 20; 21(1):580. Chauhan A, Das S, Miller R, Luque L, Cheuvront SN, Cloud J, Tarter Z, Siddiqui F, Ramirez RA, Anthony L. PMID: 34016080; PMCID: PMC8139143.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    45. PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine Tumors. Cells. 2021 05 20; 10(5). Chow Z, Johnson J, Chauhan A, Izumi T, Cavnar M, Weiss H, Townsend CM, Anthony L, Wasilchenko C, Melton ML, Schrader J, Evers BM, Rychahou P. PMID: 34065268; PMCID: PMC8160730.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    46. Radiopharmaceutical Validation for Clinical Use. Front Oncol. 2021; 11:630827. Kunos CA, Howells R, Chauhan A, Myint ZW, Bernard ME, El Khouli R, Capala J. PMID: 33747951; PMCID: PMC7966985.
      View in: PubMed   Mentions: 12  
    47. Real world clinicopathologic observations of patients with metastatic solid tumors receiving immune checkpoint inhibitor therapy: Analysis from Kentucky Cancer Registry. Cancer Med. 2021 03; 10(6):2054-2062. Jacob A, Wu J, Kolesar J, Durbin E, Mathew A, Arnold S, Chauhan A. PMID: 33619913; PMCID: PMC7957185.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    48. Gynecologic large cell neuroendocrine carcinoma: A review. Rare Tumors. 2020; 12:2036361320968401. Burkeen G, Chauhan A, Agrawal R, Raiker R, Kolesar J, Anthony L, Evers BM, Arnold S. PMID: 33194158; PMCID: PMC7605029.
      View in: PubMed   Mentions: 9  
    49. 68Ga-DOTATATE PET/CT: The Optimum Standardized Uptake Value (SUV) Internal Reference. Acad Radiol. 2022 01; 29(1):95-106. Ragab A, Wu J, Ding X, Clark A, Mischen B, Chauhan A, Oates ME, Anthony L, El Khouli R. PMID: 34756348.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    50. Clinical Application of Oncolytic Viruses: A Systematic Review. Int J Mol Sci. 2020 Oct 12; 21(20). Cook M, Chauhan A. PMID: 33053757; PMCID: PMC7589713.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    51. Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patients. Oncotarget. 2020 Aug 11; 11(32):3061-3068. Chauhan A, El-Khouli R, Waits T, Agrawal R, Siddiqui F, Tarter Z, Horn M, Weiss H, Oates E, Evers BM, Anthony L. PMID: 32850010; PMCID: PMC7429177.
      View in: PubMed   Mentions: 7     Fields:    
    52. Prognostic and predictive factors associated with ipilimumab-related adverse events: a retrospective analysis of 11 NCI-sponsored phase I clinical trials. Oncotarget. 2020 Apr 21; 11(16):1427-1434. Chauhan A, Kabir T, Wu J, Wei J, Cook M, Kunos CA. PMID: 32363000; PMCID: PMC7185063.
      View in: PubMed   Mentions:    Fields:    
    53. Immunotherapy for Medulloblastoma: Current Perspectives. Immunotargets Ther. 2020; 9:57-77. Kabir TF, Kunos CA, Villano JL, Chauhan A. PMID: 32368525; PMCID: PMC7182450.
      View in: PubMed   Mentions: 30  
    54. Neuroendocrine Tumors-Less Well Known, Often Misunderstood, and Rapidly Growing in Incidence. JAMA Oncol. 2020 01 01; 6(1):21-22. Chauhan A, Kohn E, Del Rivero J. PMID: 31697337; PMCID: PMC9382718.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    55. Two-stage phase II survival trial design. Pharm Stat. 2020 05; 19(3):214-229. Wu J, Chen L, Wei J, Weiss H, Chauhan A. PMID: 31749311; PMCID: PMC9433332.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    56. Biliary tract large cell neuroendocrine carcinoma: current evidence. Orphanet J Rare Dis. 2019 11 21; 14(1):266. Raiker R, Chauhan A, Hasanein H, Burkeen G, Horn M, Veedu J, Vela C, Arnold S, Kolesar J, Anthony L, Evers BM, Cavnar M. PMID: 31752927; PMCID: PMC6869278.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    57. Does the addition of adjuvant intraoperative tumor bed chemotherapy during midgut neuroendocrine tumor debulking procedures benefit patients? J Gastrointest Oncol. 2019 Oct; 10(5):928-934. Wang YZ, Chauhan A, Ramirez RA, Beyer DT, Stevens MA, Woltering EA, Boudreaux JP, Anthony L. PMID: 31602331; PMCID: PMC6776807.
      View in: PubMed   Mentions: 1  
    58. Neuroendocrine Tumors in Pediatrics. Glob Pediatr Health. 2019; 6:2333794X19862712. Farooqui ZA, Chauhan A. PMID: 31384627; PMCID: PMC6647200.
      View in: PubMed   Mentions: 15  
    59. Integrating a 92-Gene Expression Analysis for the Management of Neuroendocrine Tumors of Unknown Primary Asian Pac J Cancer Prev. 2019 Jan 25; 20(1):113-116. Chauhan A, Farooqui Z, Silva SR, Murray A, Hodges KB, Yu Q, Myint ZW, Raajesekar AK, Weiss H, Arnold S, Evers BM, Anthony L. PMID: 30678389; PMCID: PMC6485590.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    60. Can a High-grade Neuroendocrine Carcinoma be Functional? Am J Med Sci. 2019 03; 357(3):258-262. Graham C, Chauhan A, Anthony L. PMID: 30638597.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    61. Management of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Review and a Single Center Experience. Lung. 2018 10; 196(5):577-581. Myint ZW, McCormick J, Chauhan A, Behrens E, Anthony LB. PMID: 30167840.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    62. Capecitabine and Temozolomide in Neuroendocrine Tumor of Unknown Primary. J Oncol. 2018; 2018:3519247. Chauhan A, Farooqui Z, Murray LA, Weiss HL, War Myint Z, Raajasekar AKA, Evers BM, Arnold S, Anthony L. PMID: 29853889; PMCID: PMC5964580.
      View in: PubMed   Mentions: 9  
    63. Global burden of neuroendocrine tumors and changing incidence in Kentucky. Oncotarget. 2018 Apr 10; 9(27):19245-19254. Chauhan A, Yu Q, Ray N, Farooqui Z, Huang B, Durbin EB, Tucker T, Evers M, Arnold S, Anthony LB. PMID: 29721198; PMCID: PMC5922392.
      View in: PubMed   Mentions: 27     Fields:    
    64. Immune checkpoint inhibitors in large cell neuroendocrine carcinoma: current status. Oncotarget. 2018 Mar 06; 9(18):14738-14740. Chauhan A, Arnold SM, Kolesar J, Thomas HE, Evers M, Anthony L. PMID: 29581877; PMCID: PMC5865703.
      View in: PubMed   Mentions: 18     Fields:    
    65. Immune Checkpoint Inhibitors in Pediatric Solid Tumors: Status in 2018. Ochsner J. 2018; 18(4):370-376. Kabir TF, Chauhan A, Anthony L, Hildebrandt GC. PMID: 30559623; PMCID: PMC6292483.
      View in: PubMed   Mentions: 24  
    66. Immune checkpoint inhibitors in neuroendocrine tumors: A single institution experience with review of literature. Oncotarget. 2018 Feb 06; 9(10):8801-8809. Chauhan A, Horn M, Magee G, Hodges K, Evers M, Arnold S, Anthony L. PMID: 29507655; PMCID: PMC5823629.
      View in: PubMed   Mentions: 16     Fields:    
    67. Management of pulmonary neuroendocrine tumors. Rev Endocr Metab Disord. 2017 Dec; 18(4):433-442. Ramirez RA, Chauhan A, Gimenez J, Thomas KEH, Kokodis I, Voros BA. PMID: 28868578.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    68. The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors. Oncologist. 2016 06; 21(6):671-5. Ramirez RA, Beyer DT, Chauhan A, Boudreaux JP, Wang YZ, Woltering EA. PMID: 27226359; PMCID: PMC4912368.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    Aman's Networks
    Concepts (165)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (11)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-40-gb10dcd06 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.